Eiko LifeSciences Limited (BOM:540204)
India
· Delayed Price · Currency is INR 49.87
-0.29 (-0.58%)
At close: Apr 28, 2026
Eiko LifeSciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | 21.06 | 7.52 | 7.69 | 7.06 | 6.14 | Upgrade
|
| Depreciation & Amortization | - | 7.37 | 6.63 | 6.33 | 5.62 | 0.62 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -0.15 | - | -0.32 | - | - | Upgrade
|
| Other Operating Activities | - | -2.25 | 1.59 | -2.44 | -1.53 | -2.33 | Upgrade
|
| Change in Accounts Receivable | - | 23.48 | -60.28 | -25.43 | -11.48 | -34.15 | Upgrade
|
| Change in Inventory | - | -23.89 | -24.78 | 45.5 | -53.94 | -0.64 | Upgrade
|
| Change in Accounts Payable | - | 19.34 | 3.35 | -3.03 | -5.47 | 18.95 | Upgrade
|
| Change in Other Net Operating Assets | - | -15.72 | -4.82 | 13.94 | -17.54 | 3.16 | Upgrade
|
| Operating Cash Flow | - | 29.24 | -70.8 | 42.24 | -77.27 | -8.25 | Upgrade
|
| Capital Expenditures | - | -102.91 | -3.47 | -2.25 | -1.55 | - | Upgrade
|
| Investment in Securities | - | -31.22 | -39.64 | 2.1 | -0.03 | 4.03 | Upgrade
|
| Other Investing Activities | - | 19.69 | 37.62 | 8.89 | 6.42 | 3.58 | Upgrade
|
| Investing Cash Flow | - | -114.45 | -5.49 | 8.75 | 5.92 | -29.36 | Upgrade
|
| Long-Term Debt Issued | - | 27.63 | - | - | 27.95 | 15.63 | Upgrade
|
| Total Debt Issued | - | 27.63 | - | - | 27.95 | 15.63 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -45.53 | - | - | Upgrade
|
| Total Debt Repaid | - | - | - | -45.53 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | 27.63 | - | -45.53 | 27.95 | 15.63 | Upgrade
|
| Issuance of Common Stock | - | 43.46 | 205.05 | - | 9.5 | 63.4 | Upgrade
|
| Other Financing Activities | - | -1.54 | -1.42 | -1.5 | -4.64 | -0.88 | Upgrade
|
| Financing Cash Flow | - | 69.56 | 203.62 | -47.04 | 32.8 | 78.15 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | -0 | -0 | 0 | - | - | Upgrade
|
| Net Cash Flow | - | -15.65 | 127.34 | 3.95 | -38.55 | 40.54 | Upgrade
|
| Free Cash Flow | - | -73.67 | -74.26 | 39.99 | -78.82 | -8.25 | Upgrade
|
| Free Cash Flow Margin | - | -19.56% | -26.59% | 21.83% | -31.02% | -6.88% | Upgrade
|
| Free Cash Flow Per Share | - | -5.65 | -7.20 | 4.09 | -10.09 | -2.16 | Upgrade
|
| Cash Interest Paid | - | 1.59 | 1.42 | 1.5 | 4.64 | 0.88 | Upgrade
|
| Cash Income Tax Paid | - | 3.09 | 0.34 | -0.75 | 2.11 | 1.82 | Upgrade
|
| Levered Free Cash Flow | - | -78.93 | -77.13 | 47.74 | -92.58 | -63.62 | Upgrade
|
| Unlevered Free Cash Flow | - | -77.97 | -76.25 | 48.67 | -90.27 | -63.07 | Upgrade
|
| Change in Working Capital | - | 3.21 | -86.53 | 30.98 | -88.43 | -12.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.